Gene-environment interactions and polymorphism studies of cancer risk in the hospital-based epidemiologic research program at aichi cancer center II (HERPACC-II)

Asian Pacific Journal of Cancer Prevention

Volumn 2, Issue 2, 2001, Pages 99-107

  Hamajima, Nobuyuki ^a   Matsuo, Keitaro ^a,b   Saito, Toshiko ^a   Hirose, Kaoru ^a   Inoue, Manami ^a   Takezaki, Toshiro ^a   Kuroishi, Tetsuo ^a   Tajima, Kazuo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer risk; Case control study; Genetic polymorphism; Lifestyle; PCR CTPP

Indexed keywords

EID: 0002038292     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (39)

1. Arner P, Hoffstedt J (1999). Adrenoceptor genes in human obesity. J Intern Med, 245, 667-72.
2. Coscorbi I, Henning S, Brockmollerr J, et al (2000). Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -463A of the myeloperoxidase gene. Cancer Res, 60, 644-9.
3. Dianarello CA (1996). Biologic basis for interleukin-1 in disease. Blood, 87, 2095-2147.
4. Dunning AM, Healey CS, Pharoah PDP, et al (1999). A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarker Prev, 8, 843-54.
5. El-Omar EM, Carring M, Chow W-H, et al (2000). Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 404, 398-402
6. Feigelson HS, Coetzee GA, Kolonel LN, Ross R, Henderson BE (1997). A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res, 57, 1063-5.
7. Hamajima N, Saito T, Matsuo K, et al (2000a). Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res, 91, 865-8.
8. Hamajima N, Iwata H, Obata Y, et al (2000b). No association of the 5' promoter region polymorphism of CYP17 with breast cancer risk in Japan. Jpn J Cancer Res, 91, 880-5.
9. Hamajima N, Matsuo K, Kurobe Y (2000c). Breast cancer risk and gene polymorphisms. Jpn J Breast Cancer, 15, 123-35 (in Japanese)
10. Hamajima N (2001a). PCR-CTPP: A new genotyping technique in the era of genetic epidemiology. Expert Rev Mol Diagnosis, 1, 89-93.
11. Hamajima N, Matsuo K, Tajima K, et al (2001b). Catechol-Omethyltransferase and breast cancer in Japan. Int J Clin Oncol, 6, 13-18.
12. Hamajima N, Takezaki T, Matsuo K, et al (2001c). Genotype frequencies of cyclooxygenase 2 (COX2) rare polymorphisms for Japanese with and without colorectal cancer. Asia Pacific J Cancer Prev, 2, 57-62.
13. Hamajima N, Matsuo K, Saito T, et al (2001d). Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pyloriinfection. Jpn J Cancer Res, 92, 383-9.
14. Hamajima N, Matsuo K, Suzuki T, et al (2001e). Low exprssion myeloperoxidase negatively associated with Helicobacter pylori infection. Jpn J Cancer Res, 92, 488-93.
15. Hamajima N, Katsuda N, Matsuo K, et al (2001f). Smoking habit and interleukin 1B C-31T polymorphism. J Epidemiol, 11, 120-5.
16. Hamajima N, Matsuo K, Yuasa H (2001g). Adjustment of proqnostic effects in prevalent case-control studies on genotype. J Epidemiol (in press)
17. Huang CS, Chern HD, Chang KJ, et al (1999). Breast cancer risk associated with genotype polymorphism of the estrogenmetabolizing genes CYP17, CYP1A1, and COMT: a multigenetic study on cancer susceptibility. Cancer Res, 59, 4870-5.
18. Huang X, Hamajima N, Saito T, et al (2001). Possible association of β2 and β3 adrenergic receptor gene polymorphisms with susceptibility to breast cancer. Breast Cancer Res (in press)
19. Kamizono S, Hiromatsu Y, Seki N, et al (2000). A polymorphism of the 5'flanking region of tumour necrosis factor α gene is associated with throid-associated ophthalmopathy in Japanese. Clin Endocrinol, 52, 759-64.
20. Large C, Hellstrom L, Reynisdottir S, et al (1997). Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest, 100, 3005-13.
21. Matsuo K, Hamajima N, Tominaga S, et al (2000). Helicobacter pylori IgG antibody test established in the United States showed a substantially lower sensitivity for Japanese population. Am J Gastroenterol, 95, 1597-8.
22. Matsuo K, Hamajima N, Shinoda M, et al (2001a). Geneenvironment interaction between aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis, 22, 913-6.
23. Matsuo K, Hamajima N, Shinoda M, et al (2001b). Possible risk reduction in esophageal cancer associated with MPO -463 A allele. J Epidemiol, 11, 109-14.
24. Matsuo K, Suzuki R, Hamajima N, et al (2001c). Association between polymorphisms of folate and methionine metabolizing enzymes and susceptibility to malignant lymphoma. Blood, 97, 3205-9.
25. Moffatt MF, Cookson WOCM (1997). Tumour necrosis factor haplotypes and asthma. Hum Mol Genet, 6, 551-4.
26. Peek RM Jr, Blaser MJ, Mays DJ, et al (1999). Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res, 59, 6124-31.
27. Perera FP (2000). Molecular epidemiology: on the path to prevention? J Natl Cancer Inst, 92, 602-12.
28. Rossing MA (1998). Genetic influences on smoking: candidate genes. Environ Health Perspect, 106, 231-8.
29. Rothman KJ, Greenland S (1998). Causation and causal inference. Rothman KJ and Greenland S eds. In: Modern Epidemiology, pp7-28, Lippincott-Raven Publishers, Philadelphia
30. Sakai T, Aoyama N, Satonaka K, et al (1999). HLA-DQB1 locus and the development of atrophic gastritis with Helicobacter pylori infection. J Gastroenterol, 34 (Suppl XI), 24-7.
31. Schabath MB, Spitz MR, Zhang X, Delclos GL, Wu X (2000). Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis, 21, 1163-6.
32. Smalley W, Ray WA, Daugherty J, et al (1999). Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med, 159, 161-6.
33. Takezaki T, Hamajima N, Matsuo K, et al (2001). Association ofpolymorphisms in the beta-2 and beta-3 adrenoceptor genes with risk of colorectral cancer in Japanese. Int J Clin Oncol, 6, 117-122
34. Tajima K, Hirose K, Inoue M, et al (2000). A model of practical cancer prevention for out-patients visiting a hospital: the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Asia Pacific J Cancer Prev, 1, 35-47.
35. Vineis P, Malats N, Lnag M, et al (1999). Metabolic polymorphisms and susceptibility to cancer. IARC Scientific Publications No. 148, International Agency for Research on Cancer, Lyon.
36. Wiesner GL, Platzer P, Buxbaum S, et al (2001). Testing for colon neoplasia susceptibility variants at the human COX2 locus. J Natl Cancer Inst, 93, 635-9.
37. Ye SQ, Kwiterovich POJr (2000). Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol. Am J Clin Nutr, 72(supple), 1275S-84S.
38. Yoshida K, Hamajima N, Kozaki K, et al (2001). Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese. Cancer Epidemiol Biomark Prev,. 10, 403-5.
39. Yoshitake S, Okada M, Kimura A, Sasazuki T (1999). Contribution of major histocompatibility complex genes to susceptibility and resistence in Helicobacter pylori related diseases. Eur J Gastroenterol Hepatol, 11, 875-80.